An Assessment of the Glider Balloon in Complex Lesions
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT02396186
- Lead Sponsor
- TriReme Medical, LLC
- Brief Summary
The purpose of this study is to collect data from real-world use with the Glider Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to support the effectiveness of the Glider PTCA Balloon for crossing into complex coronary lesions.
- Detailed Description
Observational Study collecting data on commercial cases in which the Glider PTCA Balloon Catheter is used in accordance with the instructions for use. This study includes up 500 patients at up to 50 study sites.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
-
Lesion must be successfully crossed with a guidewire without complication (including Chronic Total Occlusions (CTOs))
-
The Glider balloon may only be used at one lesion during the procedure
-
The lesion in which the Glider balloon is used must be completed first
-
The primary lesion treated during the procedure must be treated with the Glider balloon
-
Intended treatment of a protocol-defined complex lesion that has at least one of the following factors:
- Significant vessel tortuosity
- Failed balloon crossing with another balloon
- Tight stenosis
- Heavy calcification
- Side branch present
- Patient < 18 years of age
- Lesion longer than 40mm
- Device use not consistent with Instructions for Use
- Patient has not given consent for their data to be submitted to this registry
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Technical Success Rate 1 hour Percentage of lesions successfully crossed among those attempted with the Glider PTCA catheter.
- Secondary Outcome Measures
Name Time Method Freedom from Balloon Slippage 1 hour Percentage of inflations with the Glider balloon in which the physician user reports no slippage.
Lesion Success Rate 48 hours Percentage of lesions with \<50% diameter stenosis, or Thrombolysis In Myocardial Infarction (TIMI) 3 flow if side branch is present, without development of MACE during hospital stay.
Trial Locations
- Locations (4)
Alexian Brothers Heart and Vascualr Institute
🇺🇸Elk Grove Village, Illinois, United States
Washington University in St. Louis
🇺🇸Saint Louis, Missouri, United States
Cardiovascular Specialists of Texas
🇺🇸Austin, Texas, United States
York Hospital
🇺🇸York, Pennsylvania, United States